ENDRA LIFE SCIENCES INC. Proceeds from Warrant Exercises
ENDRA LIFE SCIENCES INC. (NDRA) reported Proceeds from Warrant Exercises of $83.23 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-31.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromWarrantExercises · last filed 2026-03-31
- ENDRA LIFE SCIENCES INC. proceeds from warrant exercises for the quarter ending 2025-06-30 was $0.00, a 100.00% decline year-over-year.
- ENDRA LIFE SCIENCES INC. proceeds from warrant exercises for the quarter ending 2025-03-31 was $0.00, a 100.00% decline year-over-year.
- ENDRA LIFE SCIENCES INC. proceeds from warrant exercises for the quarter ending 2024-09-30 was -$1.32M.
- ENDRA LIFE SCIENCES INC. proceeds from warrant exercises for the quarter ending 2024-06-30 was $6.61M.
- ENDRA LIFE SCIENCES INC. proceeds from warrant exercises for fiscal 2025 was $83.23K.
- ENDRA LIFE SCIENCES INC. proceeds from warrant exercises for fiscal 2023 was $1.01M.
- ENDRA LIFE SCIENCES INC. proceeds from warrant exercises for fiscal 2022 was $0.00, a 100.00% decline from fiscal 2021.
- ENDRA LIFE SCIENCES INC. proceeds from warrant exercises for fiscal 2021 was $2.79M, a 41.44% decline from fiscal 2020.
| Period end | Proceeds from Warrant Exercises 3 month | Proceeds from Warrant Exercises 6 month | Proceeds from Warrant Exercises 9 month | Proceeds from Warrant Exercises 12 month |
|---|---|---|---|---|
| 2025-12-31 | $83.23K 10-K · filed 2026-03-31 | |||
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | $0.00 10-Q · filed 2025-08-14 | ||
| 2025-03-31 | $0.00 10-Q · filed 2025-05-15 | |||
| 2024-09-30 | -$1.32M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | $5.29M derived: sum of 2 quarters · filed 2025-11-14 | $5.37M 10-Q · filed 2025-11-14 | |
| 2024-06-30 | $6.61M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | $6.69M 10-Q · filed 2025-08-14 | ||
| 2024-03-31 | $77.42K 10-Q · filed 2025-05-15 | |||
| 2023-12-31 | $1.01M 10-K · filed 2024-03-28 | |||
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | $0.00 10-Q · filed 2024-08-14 | $0.00 derived: sum of 3 quarters · filed 2024-08-14 | $0.00 derived: sum of 4 quarters · filed 2024-08-14 |
| 2023-03-31 | $0.00 10-Q · filed 2024-05-14 | $0.00 derived: sum of 2 quarters · filed 2024-05-14 | $0.00 derived: sum of 3 quarters · filed 2024-05-14 | $0.00 derived: sum of 4 quarters · filed 2024-05-14 |
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | $0.00 derived: sum of 2 quarters · filed 2024-03-28 | $0.00 derived: sum of 3 quarters · filed 2024-03-28 | $0.00 10-K · filed 2024-03-28 |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $0.00 derived: sum of 2 quarters · filed 2022-11-14 | $0.00 10-Q · filed 2022-11-14 | $0.00 derived: sum of 4 quarters · filed 2023-03-16 |
| 2022-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15 | $0.00 10-Q · filed 2022-08-15 | $0.00 derived: sum of 3 quarters · filed 2023-03-16 | $0.00 derived: sum of 4 quarters · filed 2023-03-16 |
| 2022-03-31 | $0.00 10-Q · filed 2022-05-12 | $0.00 derived: sum of 2 quarters · filed 2023-03-16 | $0.00 derived: sum of 3 quarters · filed 2023-03-16 | $0.00 derived: sum of 4 quarters · filed 2023-03-16 |
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-16 | $0.00 derived: sum of 2 quarters · filed 2023-03-16 | $0.00 derived: sum of 3 quarters · filed 2023-03-16 | $2.79M 10-K · filed 2023-03-16 |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $0.00 derived: sum of 2 quarters · filed 2022-11-14 | $2.79M 10-Q · filed 2022-11-14 | $2.90M derived: sum of 4 quarters · filed 2022-11-14 |
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15 | $2.79M 10-Q · filed 2022-08-15 | $2.90M derived: sum of 3 quarters · filed 2022-08-15 | $7.49M derived: sum of 4 quarters · filed 2022-08-15 |
| 2021-03-31 | $2.79M 10-Q · filed 2022-05-12 | $2.90M derived: sum of 2 quarters · filed 2022-05-12 | $7.49M derived: sum of 3 quarters · filed 2022-05-12 | $7.50M derived: sum of 4 quarters · filed 2022-05-12 |
| 2020-12-31 | $112.93K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-30 | $4.71M derived: sum of 2 quarters · filed 2022-03-30 | $4.72M derived: sum of 3 quarters · filed 2022-03-30 | $4.76M 10-K · filed 2022-03-30 |
| 2020-09-30 | $4.59M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15 | $4.60M derived: sum of 2 quarters · filed 2021-11-15 | $4.64M 10-Q · filed 2021-11-15 | $4.64M derived: sum of 4 quarters · filed 2021-11-15 |
| 2020-06-30 | $11.20K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | $50.44K 10-Q · filed 2021-08-12 | $50.44K derived: sum of 3 quarters · filed 2021-08-12 | $50.44K derived: sum of 4 quarters · filed 2021-08-12 |
| 2020-03-31 | $39.24K 10-Q · filed 2021-05-17 | $39.24K derived: sum of 2 quarters · filed 2021-05-17 | $39.24K derived: sum of 3 quarters · filed 2021-05-17 | $39.24K derived: sum of 4 quarters · filed 2021-05-17 |
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-25 | $0.00 derived: sum of 2 quarters · filed 2021-03-25 | $0.00 derived: sum of 3 quarters · filed 2021-03-25 | $0.00 10-K · filed 2021-03-25 |
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-16 | $0.00 derived: sum of 2 quarters · filed 2020-11-16 | $0.00 10-Q · filed 2020-11-16 | |
| 2019-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-14 | $0.00 10-Q · filed 2020-08-14 | ||
| 2019-03-31 | $0.00 10-Q · filed 2020-05-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IRIDEX CORP (IRIX) | United States | $0.011B | |
| Nuwellis, Inc. (NUWE) | United States | $0.003B | |
| QT IMAGING HOLDINGS, INC. (QTI) | United States | $0.037B | |
| PRECISION OPTICS CORPORATION, INC. (POCI) | United States | $0.052B | |
| Outset Medical, Inc. (OM) | United States | $0.059B | -1.09 |
| Streamex Corp. (STEX) | United States | $0.089B | -0.19 |
| Nexalin Technology, Inc. (NXL) | United States | $0.094B | |
| Neuraxis, INC (NRXS) | United States | $0.097B | |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| Vivani Medical, Inc. (VANI) | United States | $0.111B |